H1N1 adjuvants help SAFC in Q4; Sigma sales down in 2009
Revenues fell 3 per cent in 2009 at SAFC but pharmaceutical sector demand for vaccine manufacturing products helped firm finish year with six months of growth.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs